Medicare Enrolled
Dr. Richard Phinney, M.D.
Medical Oncology · Toledo, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Phinney from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Phinney?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Phinney
Dr. Richard Phinney is a medical oncology specialist in Toledo, OH, with 18 years of NPI registration. Based on federal Medicare data, Dr. Phinney performed 118,628 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Phinney received a total of $9,833 from 31 pharmaceutical and/or device companies across 58 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Phinney is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 2% volume in OH
$9,833 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗118,628
Medicare services
Top 2% in OH for medical oncology
Not available
Unique patients (not deduplicated)
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
50,250 | $1 | $3 |
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
20,700 | $0 | $1 |
| Pembrolizumab injection (Keytruda) | 11,200 | $33 | $71 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
9,180 | $37 | $86 |
| Denosumab injection (Prolia/Xgeva) | 8,880 | $18 | $33 |
| Anti-nausea injection (aprepitant) | 5,720 | $1 | $4 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
2,600 | $6 | $25 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,231 | $0 | $0 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,420 | $1 | $7 |
| Injection, leucovorin calcium, per 50 mg | 1,116 | $3 | $13 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
714 | $2 | $7 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
694 | $91 | $208 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
402 | $92 | $253 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
369 | $21 | $58 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
344 | $10 | $48 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
237 | $61 | $141 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
223 | $2 | $42 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
204 | $1 | $3 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
185 | $11 | $42 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
171 | $45 | $130 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
150 | $6 | $158 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
138 | $40 | $83 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
116 | $15 | $36 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
112 | $1 | $3 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
109 | $1 | $10 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
107 | $20 | $54 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
103 | $9 | $29 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
99 | $2 | $9 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
97 | $51 | $140 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
92 | $47 | $117 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
78 | $16 | $46 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
73 | $128 | $500 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 69 | $133 | $596 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
67 | $24 | $107 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
64 | $61 | $148 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
63 | $116 | $320 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
47 | $15 | $39 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
44 | $40 | $116 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
38 | $67 | $141 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
29 | $4 | $12 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
28 | $24 | $61 |
| New patient office visit, complex (60-74 min) | 25 | $167 | $403 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
15 | $136 | $281 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
14 | $96 | $208 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $81 | $209 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
43.5% high complexity
55.2% medium
1.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,833
Total received (2018-2024)
Avg $1,639/year across 6 years
Top 31% in OH for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
58
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,397
2022
$539
2021
$6,214
2020
$1,038
2019
$236
2018
$409
Payments by company (2024)
PFIZER INC.
$1,200
Pinnacle Biologics, Inc
$125
Tempus AI, Inc
$36
E.R. Squibb & Sons, L.L.C.
$23
Regeneron Healthcare Solutions, Inc.
$13
Top 3 companies account for 97.4% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$6,161
PFIZER INC.
$1,215
Daiichi Sankyo Inc.
$914
Heron Therapeutics, Inc.
$174
E.R. Squibb & Sons, L.L.C.
$163
AstraZeneca Pharmaceuticals LP
$154
Pinnacle Biologics, Inc
$125
Novartis Pharmaceuticals Corporation
$116
EISAI INC.
$101
Dova Pharmaceuticals
$92
Janssen Biotech, Inc.
$92
Merck Sharp & Dohme Corporation
$76
Ipsen Biopharmaceuticals, Inc
$75
Amgen Inc.
$68
Tempus AI, Inc
$36
GENZYME CORPORATION
$24
Janssen Scientific Affairs, LLC
$24
Pharmacyclics LLC, An AbbVie Company
$22
Genentech USA, Inc.
$21
Celgene Corporation
$19
Seagen Inc.
$19
AbbVie, Inc.
$18
Merck Sharp & Dohme LLC
$16
MorphoSys, US Inc.
$14
Rigel Pharmaceuticals, Inc.
$14
Coherus Biosciences Inc.
$14
Foundation Medicine, Inc.
$14
Lilly USA, LLC
$13
Regeneron Healthcare Solutions, Inc.
$13
Exelixis Inc.
$12
Gilead Sciences, Inc.
$12
Top 3 companies account for 84.3% of all-time payments
Associated products mentioned in payments ›
AFINITOR · BALVERSA · Balversa · Cabometyx · Doptelet · ERLEADA · Enhertu · Erleada · FOUNDATIONONE · IM NAILS · IMBRUVICA · Imbruvica · JEVTANA · KANJINTI · KEYTRUDA · Kyprolis · LIBTAYO · LYNPARZA · Lenvima · MEKINIST · MONJUVI · Neulasta · Nplate · ONUREG · OPDIVO · PADCEV · PIQRAY · Phesgo · Photofrin · REBLOZYL · RYDAPT · SOMATULINE DEPOT · SUSTOL · TABRECTA · TAGRISSO · Tavalisse · Udenyca · VERZENIO · Venclexta · XALKORI · XTANDI
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
5
County median income
$60,095
Nearest hospital to ZIP centroid (approximate)
PROMEDICA TOLEDO HOSPITAL
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Phinney is a mixed practice specialist, with above-average Medicare volume (top 2% in OH), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Phinney experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Phinney performed 50,250 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Phinney receive payments from pharmaceutical companies?
Yes. Dr. Phinney received a total of $9,833 from 31 companies across 58 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Phinney's costs compare to other medical oncologists in Toledo?
Dr. Phinney's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Phinney) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Toledo
Browse medical oncologists in Toledo ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in OH
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in OH
Which OH medical oncologists receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology